Reversal effect and mechanism of arsenic trioxide on multidrug resistance of gastric carcinoma cells SGC7901

Yaoxue Xuebao

Volumn 42, Issue 9, 2007, Pages 949-953

  Xue, Ying Wei ^a   Han, Ji Guang ^a   Li, Bao Xin ^a   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic trioxide; Gastric carcinoma; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; EPIRUBICIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; ORGANOARSENIC DERIVATIVE; OXIDE; VINCRISTINE;

ADENOCARCINOMA; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; DRUG RESISTANCE; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ARSENICALS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; HUMANS; OXIDES; P-GLYCOPROTEIN; STOMACH NEOPLASMS; VINCRISTINE;

EID: 42149083881     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chan JY, Siu KP, Fung KP. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells [J]. Cancer Lett, 2006, 236:250 - 258.
2. Su CY. Role of P-glycoprotein in pharmacokinetics and its clinical implications [J]. Acta Pharm Sin, 2005, 40:673-679.
3. Lu Q, Li X, Zhang J, et al. Expression of glutathione S-transferase, P-glycoprotein, and multidrug resistance-associated protein in neuroblastoma and its clinical significance [J]. Chin J Pathol, 2002, 31:506-509.
4. Burg D, Filippov DV, Hermanns R, et al. Peptidomimetic glutathione analogues as novel gammaGT stable GST inhibitors [J]. Bioorg Med Chem, 2002, 10: 195-205.
5. Yu DQ, Yi YF. Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma [J]. Chin J Cancer, 2003, 22:496-499.
6. 3) in the treatment of acute promyelocytic leukemia [J]. Chin J Integr Tradit Chin West Med 1992, 12:170-172.
7. Zhang P, Wang SY, Hu LH. Arsenic trioxide in the treatment of 72 cases of acute promyelocytic leukemia [J]. Chin J Hematol, 1996, 16: 58-60.
8. 3 in previously untreated patients of acute promyelocytic leukemia [J]. Appl J Gen Pract, 2003, 1:182-183.
9. Wang ZG, Rivi R, Delva L, et al. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML RARα independent manner [J]. Blood, 1998, 92: 1497-1504.
10. Jiang XH, Wong BC, Yuen ST, et al. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3 [J]. Int J Cancer, 2001, 91:173-179.
11. Tu SP, Zhong J, Tan JH, et al. Induction of apoptosis by arsenic trioxide and hydroxy camptothecin in gastric cancer cells in vitro [J]. World J Gastroenterol, 2000, 6:532-539.
12. + channel blockers [J]. Acta Pharm Sin, 2005, 40:644-648.